USANA Health Sciences (USNA) Tops Q3 EPS by 10c
Get Alerts USNA Hot Sheet
Price: $14.22 -3.4%
EPS Growth %: +386.7%
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +386.7%
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.47, $0.10 better than the analyst estimate of $1.37. Revenue for the quarter came in at $191.9 million versus the consensus estimate of $190.5 million.
USANA Health Sciences sees FY2014 EPS of $5.85-$5.95, versus prior guidance of $5.5-$5.65 and the consensus of $5.53. USANA Health Sciences sees FY2014 revenue of $780-790 million, versus prior guidance of $770-790 million and the consensus of $769.5 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Hexcel falls on revenue miss and weak guidance
- Southern Missouri Bancorp (SMBC) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share